![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Ovarian Neoplasms |
|
Free Subscription
2 BMC Cancer |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Ovarian Neoplasms is free of charge.
Prognostic value of CA125, HE4, ROMA, and CPH-I in advanced epithelial ovarian
cancer.
BMC Cancer. 2026 Jun 4. doi: 10.1186/s12885-026-16291.
PubMed
Abstract available
Adjuvant pressurized intraperitoneal aerosol chemotherapy (PIPAC) in suboptimally
cytoreduced advanced ovarian cancer: a randomized phase II trial (PIPAC-OVA).
BMC Cancer. 2026 Jun 4. doi: 10.1186/s12885-026-16285.
PubMed
Abstract available
Histology-specific ADC target landscapes in ovarian cancer and therapy-associated
antigen downshift after ADC exposure.
Gynecol Oncol. 2026;210:131-139.
PubMed
Abstract available
Corrigendum to 'Endometriosis and ovarian cancer risk' [Gynecologic Oncology 209C
(2026) 88-98].
Gynecol Oncol. 2026;210:113.
PubMed
Mullerian Adenosarcoma of the Uterus, Ovary and Peritoneum: Whole Transcriptomic
Digital Spatial Profiling (DSP) in a Cohort of 42 Tumors.
Hum Pathol. 2026 Apr 1:106117. doi: 10.1016/j.humpath.2026.106117.
PubMed
Abstract available
Multi-omics and pan-cancer analysis revealed common molecular signatures to
disclose multitargeted anticancer agents through network pharmacology approach.
PLoS One. 2026;21:e0350614.
PubMed
Abstract available
Thank you for your interest in scientific medicine.